Company Profile
Catalyst Pharmaceutical Stock Price, News & Analysis
- Ticker:
- CPRX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Catalyst Pharmaceutical is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
31.40 USD (+0.06%)
Close
Last updated: June 23, 2026 at 00:00
3.84B USD
Market cap
Why the stock is moving
CPRX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Catalyst Pharmaceutical is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Catalyst Pharmaceutical is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Catalyst Pharmaceutical follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Catalyst Pharmaceutical sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Catalyst Pharmaceutical (CPRX)?
Catalyst Pharmaceutical (CPRX) most recently closed at 31.40 USD, a +0.06% move versus the previous session.
What is the market cap of Catalyst Pharmaceutical (CPRX)?
Catalyst Pharmaceutical currently has a market capitalization of 3.84B USD on BioPharmSignal.
What does Catalyst Pharmaceutical do?
Catalyst Pharmaceutical is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is CPRX stock listed?
Catalyst Pharmaceutical (CPRX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Catalyst Pharmaceutical is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Catalyst?
Catalyst Pharmaceutical is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Catalyst Pharmaceutical targeting with Catalyst?
Catalyst Pharmaceutical is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceutical?
Catalyst Pharmaceutical is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.